We’re dedicated to breaking boundaries through clinical studies and to finding new and improved ways to treat cancer that deliver better life outcomes for our patients
A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients With a High Risk of Recurrence
Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217
Cancer
MROQC
MROQC
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
CTP-2
Intensity Modulated Radiation Therapy followed by Cesium‐131 Brachytherapy for Intermediate and High Risk Localized Prostate Cancer.
Ongoing 2020 Florida West Coast
Cancer
GU005
PHASE III IGRT AND SBRT VS IGRT AND HYPOFRACTIONATED IMRT FOR LOCALIZED INTERMEDIATE RISK PROSTATE CANCER
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
GU003
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
Astellas 2215-CL-0302
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
Ongoing 2020 North Florida / Jacksonville: Astrid Corrales-Cruz (904) 427-1217
Cancer
BMS CA209-234
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217
Cancer
UTX-TGR-205
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 and TGR-1202 Alone in Patients With Previously Treated Diffuse Large B-Cell Lymphoma (UNITY-DLBCL)
Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217
Cancer
TG Therapeutics 304
A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic
Ongoing 2020 North Florida / Jacksonville: Astrid Corrales-Cruz (904) 427-1217
Cancer
PCYC-1134M
A Disease Registry for Patients with Chronic Lymphocytic Leukemia
Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217
Cancer
B-51
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Ch
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
S1806
SWOG/NRG Joint Study: Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
S1914
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
LU005
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
CC003
A Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
UTX-TGR-205-2b
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgk
Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217
Cancer
DCISionRT
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
Ongoing 2020 Florida East Coast: Peggy Mouradian (954) 370-7555 and Florida West Coast-Fort Myers: Lauren Embry (239) 344-2232
Cancer
BGB-3111-215
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrut
Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217
Cancer
EA5181
Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
BMS CA209-651
Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Study Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of t
Ongoing 2020 North Florida / Jacksonville: Astrid Corrales-Cruz (904) 427-1217
Cancer
Novocure METIS EF-25
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) (150kHz) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Ongoing 2020 Michigan: Maria Pappas (248) 553-0606
Cancer
OBS16577
A prospective, non-interventional, multinational, observational study with isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM)
Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217